Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

The pandemic caused an overall decrease in the rates of the 10 most common ophthalmic procedures performed in 2020 when ...

Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...

The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year ...

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release. The decision was ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

Some mornings you might wake up and it feels like a mission just to keep your eyes open rather than falling asleep. But this ...